Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Parkinson’s Disease Dementia

dementia risk4 - early-stage parkinsons1 - loss of balance1 - tomosyn1 - vision1 - congestive heart failure1 - omega-3s1 - transdermal rivastigmine1 - memory loss20 - age-related cognitive disorders1 - harmful cholesterol1 - dementia sufferers1 - preparing for appointment1 - aricept1 - alzheimer’s and dementia1 - dementia screening1 - miller fisher1 - risk for alzheimer disease1 - ad prognosis1 - downs syndrome1 - aripiprazole1 - genomic dna1 - aids related dementia1 - lewy body dementia2 - language impairment1 - neuroanatomical changes1 - cardiac arrest1 - blood test1 - mediterranean and dash1 - alcohol-related brain damage1 -